Therapeutic Antibodies for the Treatment of Respiratory Tract Infections—Current Overview and Perspectives

Respiratorytract infections (RTIs) are frequent and life-threatening diseases, accounting for several millions of deaths worldwide. RTIs implicate microorganisms, including viruses (influenza virus, coronavirus, respiratory syncytial virus (RSV)), bacteria (<i>Pseudomonas aeruginosa</i>, <i>Streptoc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alexie Mayor, Adélaïde Chesnay, Guillaume Desoubeaux, David Ternant, Nathalie Heuzé-Vourc’h, Thomas Sécher
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2021-02-01
coleção:	Vaccines
Assuntos:	therapeutic antibodies respiratory tract infection pharmacodynamics (PD) pharmacokinetics (PK) clinical development
Acesso em linha:	https://www.mdpi.com/2076-393X/9/2/151
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!